4basebio PLC (AIM:4BB)
London · Delayed Price · Currency is GBP · Price in GBX 790.00
0.00 (0.00%)
Oct 31, 2025, 9:46 AM GMT+1
4basebio Market Cap
4basebio has a market cap or net worth of 122.27 million as of October 31, 2025. Its market cap has decreased by -26.27% in one year.
Market Cap
122.27M
Enterprise Value
111.60M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
790.00
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 122.27M, an increase of 194.12%. That is a compound annual growth rate of 25.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 122.27M | -21.09% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
| Feb 17, 2021 | 41.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.57B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |